From the CMS doc “Medicare Drug Worth Negotiation Program: Chosen Medication for Preliminary Worth
Applicability 12 months 2027“:
On January 17, 2025, CMS introduced the number of the under checklist of 15 medication lined beneath Medicare Half D for the second cycle of negotiations (preliminary value applicability yr 2027), based mostly on whole gross lined prescription drug prices beneath Medicare Half D and different standards as required by the legislation.
With the Trump inauguration to happen on Monday, will the Medicare Drug Worth Negotiation course of change with the brand new administration? Anna Kaltenboeck notes in EndPoints Information:
…the following administration is not going to have “blanket authority to vary the core components of the legislation,” sure facets of the method will be modified with out legislative motion.
For instance, CMS might alter its steering or the way it interprets components of the legislation, corresponding to what number of occasions it meets with drugmakers, or what number of listening classes it holds. “The diploma to which they play hardball with producers within the course of might change,” she mentioned.
